Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - Concepedia

Concepedia

Publication | Open Access

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

DOI Full Paper Access

427

Citations

27

References

2021

Year

Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford, Mahdi Mahdi, Helen Jeffers, Christine Mwasuku, Karolina Krassowska, Robin Fox, Ian Binnian, Victoria Glover,

The Lancet Respiratory Medicine

Early Covid-19Respiratory DiseasesRespiratory InfectionInfectious Respiratory DiseasePulmonary MedicinePhase 2MedicinePulmonary DiseaseCovid-19

References

	Year	Citations

Page 1

Page 1